MONHEIM AM RHEIN, Germany & SAN JOSE, Calif.--(BUSINESS WIRE)--Resolve Biosciences today announced the commercial launch of its groundbreaking Molecular Cartographyâ„¢ service offering to provide ...
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival of approximately 12 months for patients with extensive-stage disease Precede ...
Comprehensive epigenomic platform enables systematic and quantitative prediction of tumor gene expression from cell-free DNA Genes include key targets for next generation precision medicines, such as ...